Microbix Biosystems Inc. MBX.TO
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -26.48% | -34.42% | -28.82% | -29.00% | -12.08% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -26.48% | -34.42% | -28.82% | -29.00% | -12.08% |
| Cost of Revenue | -10.21% | -10.87% | -13.49% | -15.11% | -9.14% |
| Gross Profit | -39.42% | -51.68% | -40.83% | -38.02% | -14.29% |
| SG&A Expenses | 4.01% | 3.55% | 5.73% | -7.84% | -6.82% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.48% | -2.94% | -4.29% | -9.79% | -6.71% |
| Operating Income | -660.95% | -323.04% | -241.16% | -135.18% | -65.14% |
| Income Before Tax | -2,706.51% | -437.29% | -307.56% | -162.12% | -103.40% |
| Income Tax Expenses | -136.68% | -136.68% | -136.68% | -136.68% | -- |
| Earnings from Continuing Operations | -1,387.10% | -466.66% | -321.07% | -163.20% | -106.34% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1,387.10% | -466.66% | -321.07% | -163.20% | -106.34% |
| EBIT | -660.95% | -323.04% | -241.16% | -135.18% | -65.14% |
| EBITDA | -222.63% | -192.65% | -148.14% | -94.91% | -39.91% |
| EPS Basic | -1,606.67% | -463.41% | -319.80% | -162.23% | -105.47% |
| Normalized Basic EPS | -16,300.00% | -431.58% | -304.35% | -160.48% | -98.39% |
| EPS Diluted | -1,195.00% | -478.75% | -329.29% | -165.96% | -107.30% |
| Normalized Diluted EPS | -16,300.00% | -431.58% | -304.35% | -160.48% | -98.39% |
| Average Basic Shares Outstanding | -0.75% | 0.47% | 1.14% | 0.11% | 1.46% |
| Average Diluted Shares Outstanding | -1.12% | -0.04% | 0.57% | -0.22% | 1.39% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |